Rudolf Benz
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial.Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich
|Oct 14, 2023
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.Kira-Lee Koster, Nora-Medea Messerich, Thomas Volken
|Mar 11, 2023
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.Nora-Medea Messerich, Narasimha Rao Uda, Thomas Volken
|Jul 02, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle
|Dec 29, 2020
Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement.Ioannis Chanias, C Matthias Wilk, Rudolf Benz
|May 26, 2020
Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis.Rudolf Benz, Kathrin Zimmermann, Markus Rechsteiner
Pageof 2
Frequent Collaborators
2 joint publications
Georg Stüssi
2 joint publications
Adrian Schmidt
2 joint publications
Ulrike Bacher
2 joint publications
Nicolas Bonadies
2 joint publications
Tobias Silzle
2 joint publications
Thomas Volken
2 joint publications
Wolfram Jochum
1 joint publications
Sabine Majer
1 joint publications
C Matthias Wilk
1 joint publications
Martin Andres
